2017
DOI: 10.1186/s13036-016-0044-1
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for using nanoprobes to perceive and treat cancer activity: a review

Abstract: Nanomedicine has seen a significant increase in research on stimuli-responsive activatable nanoprobes for tumor-specific delivery and diagnosis. The tumor microenvironment has particular characteristics that can be exploited to implement therapeutic strategies based on disparities between normal tissues and tumor tissues, including differences in pH, oxygenation, enzymatic expression, gene activation/inactivation, and vasculature. The nanocarriers of activatable nanoparticles maintain their structure while cir… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 68 publications
0
3
0
1
Order By: Relevance
“…The increased uptake of anti-EGFR– p MBA–MGNs in cells clearly shows that (i) EGFR receptors are overexpressed in MDA-MB-231 cells, as supported by our fluorescence assay in Figure S1, (ii) active targeting of MGNs is enabled likely by both surface-bound receptors and receptor-mediated endocytosis, and (iii) MGNs without antibodies have a low passive uptake in cells within 16 h of incubation. , Unlike the spindle morphology of the MDA-MB-231 cells, these MCF7 cells have more of a brick-shaped morphology and tend to grow in closer proximity to one another (Figure d). Phase contrast images clearly demonstrated that MGNs are not bound to cells either via active targeting (Figure e) or via passive uptake (Figure f).…”
Section: Results and Discussionmentioning
confidence: 58%
“…The increased uptake of anti-EGFR– p MBA–MGNs in cells clearly shows that (i) EGFR receptors are overexpressed in MDA-MB-231 cells, as supported by our fluorescence assay in Figure S1, (ii) active targeting of MGNs is enabled likely by both surface-bound receptors and receptor-mediated endocytosis, and (iii) MGNs without antibodies have a low passive uptake in cells within 16 h of incubation. , Unlike the spindle morphology of the MDA-MB-231 cells, these MCF7 cells have more of a brick-shaped morphology and tend to grow in closer proximity to one another (Figure d). Phase contrast images clearly demonstrated that MGNs are not bound to cells either via active targeting (Figure e) or via passive uptake (Figure f).…”
Section: Results and Discussionmentioning
confidence: 58%
“…An efficient nano–chemotherapeutic system should improve the therapeutic effects of drugs on diseased tissues while reducing its side effects on healthy tissues and organs. , Considering the differences between normal and tumoral tissues in the lymphatic system, capillary walls of blood vessels, and pH levels, , body-intrinsic stimuli-responsive nanosystems are in the focus of recent studies. Among them, pH-responsive drug carriers have been mainly investigated since they are able to release the cargo drugs only at the site of the action in the acidic microenvironment of the diseased tissue and in the acidic organelles of cells.…”
Section: Introductionmentioning
confidence: 99%
“…The degradation percentage of Mg-ACP/PAA nanoparticles was 72.4% when soaked in an acidic solution (pH = 5.0) for 1 h, which showed improved degradation efficiency than hybrid organosilica nanoparticles. Our results suggest that pH-sensitive Mg-ACP/PAA nanoparticles can be efficiently degraded by lysosomes, which are good candidates for the delivery of drugs and other therapeutic molecules [ 62 ].…”
Section: Discussionmentioning
confidence: 99%